ESC 365 - Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation: Final Phase II results of the GLORIA-AF Registry Program

EHRA Premium Access

Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation: Final Phase II results of the GLORIA-AF Registry Program

Session: Late-breaking science - Registries

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Speaker: Professor G. Lip (Liverpool, GB)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

100 presentations

9 followers

6 more presentations in this session

Safety and acute effectiveness of a new ultra-high density mapping system for ablation of arrhythmias.

Speaker: Professor G. Hindricks (Berlin, DE)

Ablation of paroxysmal and persistent atrial fibrillation using a flexible tip ablation catheter: Outcomes from the ABLATOR registry

Speaker: Doctor Y. Yao (Beijing, CN)

Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21,141 procedures in the Helios atrial fibrillation ablation registry (SAFER)

Speaker: Doctor L. Ueberham (Leipzig, DE)

Evaluating real-life clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology

Speaker: Professor L. Boersma (Nieuwegein, NL)

Optimization of ICD programming in practice- diffusion rate of clinical trial results and consensus recommendations measured in a large cohort of implantable cardioverter defibrillator patients

Speaker: Doctor N. Varma (Cleveland, US)

Access the full session

Late-breaking science - Registries

Speakers: Professor G. Lip, Professor G. Hindricks, Doctor Y. Yao, Doctor L. Ueberham, Professor L. Boersma...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources